Literature DB >> 25918289

Localized and systemic approaches to treating hepatocellular carcinoma.

Jennifer J Knox1, Sean P Cleary2, Laura A Dawson2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25918289     DOI： 10.1200/JCO.2014.60.1153

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  20 in total

1.  Special Series: Advances in GI Cancer.

Authors:  Jeffrey A Meyerhardt; Joel E Tepper; Alan P Venook
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

Review 2.  Computed tomography imaging assessment of postexternal beam radiation changes of the liver.

Authors:  Michael Lock; Ashkan A Malayeri; Omar Y Mian; Nina A Mayr; Joseph M Herman; Simon S Lo
Journal:  Future Oncol       Date:  2016-08-31       Impact factor: 3.404

3.  PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma.

Authors:  Chang-Long Chen; Qiu-Zhong Pan; Jing-Jing Zhao; Ying Wang; Yong-Qiang Li; Qi-Jing Wang; Ke Pan; De-Sheng Weng; Shan-Shan Jiang; Yan Tang; Xiao-Fei Zhang; Hong-Xia Zhang; Zi-Qi Zhou; Yi-Xin Zeng; Jian-Chuan Xia
Journal:  Oncoimmunology       Date:  2016-05-31       Impact factor: 8.110

4.  The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib.

Authors:  Umut Sarpel; John H Spivack; Yaniv Berger; Marina Heskel; Samantha N Aycart; Robert Sweeney; Martin P Edwards; Daniel M Labow; Edward Kim
Journal:  HPB (Oxford)       Date:  2016-03-17       Impact factor: 3.647

5.  Central role of lactate and proton in cancer cell resistance to glucose deprivation and its clinical translation.

Authors:  Xun Hu; Ming Chao; Hao Wu
Journal:  Signal Transduct Target Ther       Date:  2017-03-10

6.  Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study.

Authors:  Lei Liang; Bing Quan; Han Wu; Yong-Kang Diao; Jie Li; Ting-Hao Chen; Yao-Ming Zhang; Ya-Hao Zhou; Wan-Guang Zhang; Hong Wang; Matteo Serenari; Matteo Cescon; Myron Schwartz; Yong-Yi Zeng; Ying-Jian Liang; Hang-Dong Jia; Hao Xing; Chao Li; Ming-Da Wang; Wen-Tao Yan; Wan-Yuan Chen; Wan Yee Lau; Cheng-Wu Zhang; Timothy M Pawlik; Dong-Sheng Huang; Feng Shen; Tian Yang
Journal:  Hepatol Int       Date:  2021-02-03       Impact factor: 6.047

7.  Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and Radiotherapy.

Authors:  Jinhong Jung; Ji Hyeon Joo; So Yeon Kim; Jin Hyoung Kim; Jonggi Choi; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Jin-Hong Park; Sang Min Yoon
Journal:  Liver Cancer       Date:  2021-12-07       Impact factor: 12.430

Review 8.  MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance.

Authors:  Ulrich H Weidle; Daniela Schmid; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

9.  Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE.

Authors:  Jan B Hinrichs; Hoen-Oh Shin; Daniel Kaercher; Davut Hasdemir; Tim Murray; Till Kaireit; Carolin Lutat; Arndt Vogel; Bernhard C Meyer; Frank K Wacker; Thomas Rodt
Journal:  Eur Radiol       Date:  2016-01-14       Impact factor: 5.315

10.  Association of Sarcopenia and Body Composition With Short-term Outcomes After Liver Resection for Malignant Tumors.

Authors:  Giammauro Berardi; Giulio Antonelli; Marco Colasanti; Roberto Meniconi; Nicola Guglielmo; Andrea Laurenzi; Stefano Ferretti; Giovanni Battista Levi Sandri; Alessandra Spagnoli; Giovanni Moschetta; Vincenzo Schininà; Mario Antonini; Massimo Marignani; Giuseppe Maria Ettorre
Journal:  JAMA Surg       Date:  2020-11-18       Impact factor: 14.766
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.